Form4insider filings, from the source

SEC Form 4 · accession 0001179110-18-009105

Kezar Life Sciences, Inc. · KZR

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Period of report
Jun 25, 2018
Accepted (ET)
Jun 28, 2018 · 6:22 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001645666

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1,F2,F3Jun 25, 2018C472,229—A472,229ISee Footnotes
Common StockF2,F3Jun 25, 2018P150,000$15.00A622,229ISee Footnotes

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Series B Redeemable Convertible Preferred StockF1,F2,F3—Jun 25, 2018C472,229D——Common Stock472,2290I

Explanation of responses